secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2026-07-15T14:38:08+00:00
Accession:  0001753926-26-001173
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 1.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals files Chapter 11, sells substantially all assets to XRAIY LLC
--------------------------------------------------------------------------------

- Filed Chapter 11 on March 30, 2026 in Western District of Pennsylvania.
- Entered Asset Purchase Agreement with XRAIY LLC on May 14, 2026 to sell substantially all assets.
- Bankruptcy Court approved sale on June 4, 2026 via Sale Order.
- Company warns common stock trading is highly speculative; recovery for shareholders uncertain.
- Sale is free and clear of liens, claims, and encumbrances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392626001173/0001753926-26-001173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392626001173/g085807_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-001173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer